OSUR — OraSure Technologies Share News
0.000.00%
Last trade - 00:00- $262.77m
- $102.39m
- $115.02m
U.S. RESEARCH ROUNDUP- Airbnb, Coca-Cola, Marriott
OraSure Technologies Inc reports results for the quarter ended in December - Earnings Summary
Brief: Orasure Reports 4Q22 Revenue Of $123.1 Mln Growing 94% Year-Over-Year
Brief: OraSure Technologies Reports 4Q22 Results, Provides Q1 2023 Outlook
OraSure Technologies Inc expected to post a loss of 1 cent a share - Earnings Preview
Brief: Orasure Technologies Gets U.S. Defense Logistics Agency Second Procurement Contract For Inteliswab Covid-19 Rapid Test
OraSure Technologies Inc reports results for the quarter ended in September - Earnings Summary
Brief: OraSure Reports Q3 Record Revenue Of $116.5 Million, Growing 116% Year-Over-Year
OraSure Technologies Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Orasure Technologies Receives FDA Clearance For OracollectDx Device For OTC Use
Brief: Inteliswab COVID-19 Rapid Test Now Available In Amazon's Online Store
OraSure Technologies Inc expected to post a loss of 4 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Heartbeam, Aura Biosciences, U.S. banks
U.S. STOCKS ON THE MOVE-Airlines, Thor Industries, TCR2 Therapeutics
OraSure Technologies up on U.S. govt contract to develop Ebola test
Brief: OraSure Technologies Receives $8.6 Million BARDA Contract To Develop 2nd Generation Ebola Test
Brief: Orasure Wins Contract To Supply “Together Take Me Home,” HIV Self-Testing Initiative Sponsored By The Centers For Disease Control And Prevention
Brief: Orasure Partners With Mars Petcare In One Of The Largest Ever Microbiome Studies To Evaluate Pet Health
Brief: Orasure Technologies Inc - On August 8, 2022, Board Appointed Ken Mcgrath As Company's Chief Financial Officer, Effective August 8, 2022